DPP4 and pancreatitis: Post-marketing surveillance and case reports have identified isolated cases of pancreatitis associated with the use of DPP-4 inhibitors, although some large-scale studies and meta-analyses have not found significantly increased rates of pancreatitis compared to comparators [23].